LON:IDH - Immunodiagnostic Systems Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
GBX 175 0.00 (0.00 %)
(As of 04/21/2019 04:00 PM ET)
Previous CloseGBX 175
Today's RangeGBX 175 - GBX 175
52-Week RangeGBX 160 - GBX 276
VolumeN/A
Average Volume1,203 shs
Market Capitalization£50.37 million
P/E RatioN/A
Dividend Yield0.91%
BetaN/A
Immunodiagnostic Systems Holdings PLC provides in-vitro diagnostic solutions to the clinical laboratory market in the United Kingdom, the United States, Germany, France, and internationally. It develops, manufactures, and markets immunoassays and automated immunoanalyser technologies to provide diagnostic outcomes for patients. It offers IDS-iSYS multi-discipline automated systems and manual assays for use in clinical areas, such as bone and calcium metabolism, chronic kidney and mineral bone disorders, fertility, growth disorders, hypertension, autoimmunity, infectious disease, and biochemistry. Immunodiagnostic Systems Holdings PLC was founded in 1977 and is headquartered in Boldon, the United Kingdom.

Receive IDH News and Ratings via Email

Sign-up to receive the latest news and ratings for IDH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Appliances & Equipment
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-191-5190660

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£37.79 million
Cash FlowGBX 96.40 per share
Book ValueGBX 192.70 per share

Profitability

Miscellaneous

Employees286
Market Cap£50.37 million
Next Earnings DateN/A
OptionableNot Optionable

Immunodiagnostic Systems (LON:IDH) Frequently Asked Questions

What is Immunodiagnostic Systems' stock symbol?

Immunodiagnostic Systems trades on the London Stock Exchange (LON) under the ticker symbol "IDH."

How often does Immunodiagnostic Systems pay dividends? What is the dividend yield for Immunodiagnostic Systems?

Immunodiagnostic Systems declared a dividend on Wednesday, June 20th. Shareholders of record on Thursday, July 19th will be paid a dividend of GBX 1.70 per share on Friday, August 17th. This represents a yield of 0.67%. The ex-dividend date of this dividend is Thursday, July 19th. The official announcement can be viewed at this link. View Immunodiagnostic Systems' Dividend History.

How were Immunodiagnostic Systems' earnings last quarter?

Immunodiagnostic Systems Holdings PLC (LON:IDH) issued its quarterly earnings results on Wednesday, June, 20th. The company reported $5.70 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $2.60 by $3.10. View Immunodiagnostic Systems' Earnings History.

Has Immunodiagnostic Systems been receiving favorable news coverage?

News articles about IDH stock have been trending neutral this week, according to InfoTrie Sentiment Analysis. The research firm scores the sentiment of news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Immunodiagnostic Systems earned a media sentiment score of 0.4 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 1.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term.

Who are some of Immunodiagnostic Systems' key competitors?

What other stocks do shareholders of Immunodiagnostic Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Immunodiagnostic Systems investors own include Dechra Pharmaceuticals (DPH), iShares Nasdaq Biotechnology ETF (IBB), Micron Technology (MU), Lendlease Group (LLC), Velocity Data (VCT), Redrow (RDW), Majestic Wine (WINE), YouGov (YOU), Ctrip.Com International (CTRP) and New Age Beverages (NBEV).

Who are Immunodiagnostic Systems' key executives?

Immunodiagnostic Systems' management team includes the folowing people:
  • Mr. Jaap Stuut, CEO & Director (Age 49)
  • Mr. Paul J. Martin, Group Fin. Director, Company Sec. & Director
  • Nicola Trewin, Group HR Director
  • Mr. Ed Coombes, Head Of Bus. Devel. - Instrumentation (Age 48)
  • Dr. Rudolf Schemer, CEO of GeschTMaftsfuhrer at IDS GmbH Frankfurt & Country Mang. of Germany Region (Age 58)

How do I buy shares of Immunodiagnostic Systems?

Shares of IDH and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Immunodiagnostic Systems' stock price today?

One share of IDH stock can currently be purchased for approximately GBX 175.

How big of a company is Immunodiagnostic Systems?

Immunodiagnostic Systems has a market capitalization of £50.37 million and generates £37.79 million in revenue each year. Immunodiagnostic Systems employs 286 workers across the globe.

What is Immunodiagnostic Systems' official website?

The official website for Immunodiagnostic Systems is http://www.idsplc.com/.

How can I contact Immunodiagnostic Systems?

Immunodiagnostic Systems' mailing address is 10 Didcot Way, BOLDON, NE35 9PD, United Kingdom. The company can be reached via phone at +44-191-5190660.


MarketBeat Community Rating for Immunodiagnostic Systems (LON IDH)

Community Ranking:  1.6 out of 5 (star)
Outperform Votes:  86 (Vote Outperform)
Underperform Votes:  182 (Vote Underperform)
Total Votes:  268
MarketBeat's community ratings are surveys of what our community members think about Immunodiagnostic Systems and other stocks. Vote "Outperform" if you believe IDH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IDH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/21/2019 by MarketBeat.com Staff

Featured Article: Economic Reports

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel